Genetic risk factor of COPD
Even if an individual has never smoked or been unprotected to pollutants for an extended period of time, they can still develop COPD. Alpha-1 Antitrypsin Deficiency (AATD) is the most commonly known genetic risk factor of COPD in emphysema. Alpha-1 Antitrypsin related COPD is caused by a deficiency of the Alpha-1 in the bloodstream. Without the Alpha-1 Antitrypsin protein, white blood cells begin to harm the lungs and lung deterioration occurs. The World Health Organization and the American Thoracic Society suggests that each individual determined to have COPD be tested for Alpha-1. Pulmonary Conferences also discusses about different types of genes which may be a cause of pulmonary diseases.
Related Conference of Genetic risk factor of COPD
October 22-23, 2025
5th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
Genetic risk factor of COPD Conference Speakers
Recommended Sessions
- Co-Morbidities of COPD
- Drug Discovery of COPD
- Asthma and COPD
- Chronic Obstructive Pulmonary Disease
- COPD and Cardiovascular Diseases
- COPD Complications
- COPD Exacerbations
- COPD Pathogenesis
- COPD Therapeutics
- COPD: Sign and Symptoms
- Depression and anxiety in COPD
- Epidemiology of COPD
- Genetic risk factor of COPD
- Lung cancer
- Pathophysiology of COPD
- Pediatric Pulmonary, Critical care and Sleep
- Pulmonary diseases-treatment and therapies
- Pulmonary Hypertension
- Self-Management and Prevention of COPD
- Types of COPD
Related Journals
Are you interested in
- Asthma - Pulmonary Meet 2025 (France)
- Asthma and Allergy - COPD CONGRESS-2025 (Italy)
- Asthma Management - COPD SUMMIT 2025 (Italy)
- Asthma-COPD Overlap - COPD SUMMIT 2025 (Italy)
- Cardio Pulmonary Disorders - COPD CONGRESS-2025 (Italy)
- Chronic bronchitis - COPD CONGRESS-2025 (Italy)
- Chronic Bronchitis - Pulmonary Meet 2025 (France)
- Chronic obstructive pulmonary disease - COPD CONGRESS-2025 (Italy)
- Chronic Obstructive Pulmonary Disease - COPD SUMMIT 2025 (Italy)
- Clinical Immunology & Genetics - COPD SUMMIT 2025 (Italy)
- Clinical Trials - COPD SUMMIT 2025 (Italy)
- COPD - Pulmonary Meet 2025 (France)
- COPD and Air Pollution - COPD CONGRESS-2025 (Italy)
- COPD Pathogenesis - COPD CONGRESS-2025 (Italy)
- COPD Pathogenesis - COPD SUMMIT 2025 (Italy)
- COPD Preventative Measures - COPD SUMMIT 2025 (Italy)
- COPD-Chronic obstructive pulmonary disease - COPD CONGRESS-2025 (Italy)
- Cystic Fibrosis - Pulmonary Meet 2025 (France)
- Depression and Anxiety in COPD - COPD CONGRESS-2025 (Italy)
- Depression and Anxiety in COPD - COPD SUMMIT 2025 (Italy)
- Diagnosis and Treatment of COPD - COPD SUMMIT 2025 (Italy)
- Diagnosis and Treatment of COPD - COPD CONGRESS-2025 (Italy)
- Drug Discovery of COPD - COPD CONGRESS-2025 (Italy)
- Drug Discovery of COPD - COPD SUMMIT 2025 (Italy)
- Effect of COVID-19 on Lungs - COPD SUMMIT 2025 (Italy)
- Effect of COVID-19 on Lungs - COPD CONGRESS-2025 (Italy)
- Emphysema - COPD CONGRESS-2025 (Italy)
- Emphysema - Pulmonary Meet 2025 (France)
- Epidemiology - COPD SUMMIT 2025 (Italy)
- Experimental Models - COPD SUMMIT 2025 (Italy)
- Infectious Respiratory Diseases - Pulmonary Meet 2025 (France)
- Interstitial lung disease - Pulmonary Meet 2025 (France)
- Lung and COVID-19 - COPD SUMMIT 2025 (Italy)
- Lung cancer - COPD CONGRESS-2025 (Italy)
- Lung Cancer - Pulmonary Meet 2025 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - COPD CONGRESS-2025 (Italy)
- Lung problems - Pulmonary Meet 2025 (France)
- Lung transplantation - Pulmonary Meet 2025 (France)
- Lung Transplantation - COPD SUMMIT 2025 (Italy)
- Lung Transplantation - COPD CONGRESS-2025 (Italy)
- Pathophysiology & Pharmacology - COPD SUMMIT 2025 (Italy)
- Pediatric Neonatal Care in COPD - COPD CONGRESS-2025 (Italy)
- Pediatric Pulmonology & Critical care - COPD CONGRESS-2025 (Italy)
- Pharmacological and Non-Pharmacological Treatments - COPD SUMMIT 2025 (Italy)
- Pleural Diseases - Pulmonary Meet 2025 (France)
- Prevention and Control of Respiratory disease - Pulmonary Meet 2025 (France)
- Prevention of COPD - COPD CONGRESS-2025 (Italy)
- Pulmonary diseases - COPD CONGRESS-2025 (Italy)
- Pulmonary Hypertension - Pulmonary Meet 2025 (France)
- Pulmonary Rehabilitation - COPD CONGRESS-2025 (Italy)
- Pulmonary Rehabilitation - COPD SUMMIT 2025 (Italy)
- Pulmonary Rehabilitation - Pulmonary Meet 2025 (France)
- Pulmonary vascular disease - Pulmonary Meet 2025 (France)
- Pulmonology - Pulmonary Meet 2025 (France)
- Respiratory and sleep Medicine - COPD CONGRESS-2025 (Italy)
- Respiratory Disorders - Pulmonary Meet 2025 (France)
- Respiratory Failure - COPD SUMMIT 2025 (Italy)
- Respiratory Tract Infections - Pulmonary Meet 2025 (France)
- Respiratory Tract Infections - COPD CONGRESS-2025 (Italy)
- Self-Management and Prevention of COPD - COPD CONGRESS-2025 (Italy)
- Self-Management and Prevention of COPD - COPD SUMMIT 2025 (Italy)
- Sleep-Related Respiratory Disorders - Pulmonary Meet 2025 (France)
- Spirometry - COPD CONGRESS-2025 (Italy)
- Spirometry - COPD SUMMIT 2025 (Italy)
- Stages & Severity on Lung Diseases - COPD CONGRESS-2025 (Italy)
- Tobacco control - COPD CONGRESS-2025 (Italy)
- Tuberculosis - Pulmonary Meet 2025 (France)
- Types of COPD - COPD CONGRESS-2025 (Italy)